UniQuest is the commercialisation company of The University of Queensland (UQ), Australia. In partnership with UQ researchers, we create impact through the commercialisation of UQ intellectual property.
UQ/UniQuest is the originator of multiple global success stories including Vicebio/Sanofi, Inflazome/Roche, Spinifex/Novartis, ResApp/Pfizer, Gardasil/Merck and Protagonist (NASDAQ: PTGX). UniQuest has recently established the UniQuest Extension Fund with A$32M investment fund to support the start-up ecosystem at UQ and co-invest into UniQuest start-ups.
Address
BrisbaneQueensland
Australia
